| scholarly article | Q13442814 |
| P50 | author | Wendy Barclay | Q20005716 |
| Michael Henry Malim | Q21166756 | ||
| Olivier Moncorgé | Q55743797 | ||
| P2093 | author name string | Caroline Goujon | |
| Tomas Doyle | |||
| Hélène Bauby | |||
| P2860 | cites work | Mechanisms for the Inhibition of HIV Replication by Interferons-α, -β, and -γ, in Primary Human Macrophages | Q42278001 |
| GTP-bound human MxA protein interacts with the nucleocapsids of Thogoto virus (Orthomyxoviridae). | Q42819861 | ||
| Interferon-induced protein Mx accumulates in nuclei of mouse cells expressing resistance to influenza viruses. | Q54456249 | ||
| Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro. | Q55245135 | ||
| Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction | Q68158031 | ||
| Inhibition of nuclear import and cell-cycle progression by mutated forms of the dynamin-like GTPase MxB | Q24295362 | ||
| HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency | Q24300016 | ||
| Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing | Q24318920 | ||
| Human MxB protein, an interferon-alpha-inducible GTPase, contains a nuclear targeting signal and is localized in the heterochromatin region beneath the nuclear envelope | Q24321804 | ||
| Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection | Q24336824 | ||
| MX2 is an interferon-induced inhibitor of HIV-1 infection | Q24338311 | ||
| Antiviral actions of interferons | Q24550676 | ||
| cDNA structures and regulation of two interferon-induced human Mx proteins | Q24631222 | ||
| Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein | Q24649045 | ||
| Dominant-negative mutants of human MxA protein: domains in the carboxy-terminal moiety are important for oligomerization and antiviral activity | Q24677786 | ||
| Regulation of type I interferon responses | Q26853177 | ||
| Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein | Q27480330 | ||
| Structure of myxovirus resistance protein a reveals intra- and intermolecular domain interactions required for the antiviral function | Q27674633 | ||
| Self-assembly of human MxA GTPase into highly ordered dynamin-like oligomers | Q28201712 | ||
| Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies | Q28206468 | ||
| Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines | Q28339753 | ||
| Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A | Q28379060 | ||
| Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids | Q29040504 | ||
| In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector | Q29547503 | ||
| The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys | Q29547689 | ||
| Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures | Q29615028 | ||
| The viral nucleoprotein determines Mx sensitivity of influenza A viruses | Q30403933 | ||
| Pandemic influenza A viruses escape from restriction by human MxA through adaptive mutations in the nucleoprotein | Q30429005 | ||
| Differential effects of human immunodeficiency virus type 1 capsid and cellular factors nucleoporin 153 and LEDGF/p75 on the efficiency and specificity of viral DNA integration | Q30452981 | ||
| Interferon-Alpha Mediates Restriction of Human Immunodeficiency Virus Type-1 Replication in Primary Human Macrophages at an Early Stage of Replication | Q33728042 | ||
| Flexible use of nuclear import pathways by HIV-1. | Q33739260 | ||
| Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein | Q33865474 | ||
| Mechanism of human MxA protein action: variants with changed antiviral properties | Q33937693 | ||
| Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes | Q34016778 | ||
| Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells | Q34120302 | ||
| The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1 | Q34140181 | ||
| Comparison of gene transfer efficiencies and gene expression levels achieved with equine infectious anemia virus- and human immunodeficiency virus type 1-derived lentivirus vectors | Q34328548 | ||
| Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection | Q35018048 | ||
| Nucleoporin NUP153 phenylalanine-glycine motifs engage a common binding pocket within the HIV-1 capsid protein to mediate lentiviral infectivity | Q35018068 | ||
| Stalk domain of the dynamin-like MxA GTPase protein mediates membrane binding and liposome tubulation via the unstructured L4 loop | Q35424269 | ||
| IFN-inducible GTPases in host cell defense | Q36374867 | ||
| Evolution-guided identification of antiviral specificity determinants in the broadly acting interferon-induced innate immunity factor MxA. | Q36520909 | ||
| Myxovirus resistance gene A (MxA) expression suppresses influenza A virus replication in alpha interferon-treated primate cells | Q36559577 | ||
| Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity | Q37821936 | ||
| Viral and cellular requirements for the nuclear entry of retroviral preintegration nucleoprotein complexes | Q38150610 | ||
| Interferon-stimulated genes: roles in viral pathogenesis | Q38203069 | ||
| A functional GTP-binding motif is necessary for antiviral activity of Mx proteins | Q38314550 | ||
| Mouse Mx2 protein inhibits vesicular stomatitis virus but not influenza virus | Q38329807 | ||
| Protein transfer into human cells by VSV-G-induced nanovesicles. | Q38585869 | ||
| The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm. | Q39094210 | ||
| Evidence for a different susceptibility of primate lentiviruses to type I interferons. | Q39223017 | ||
| Unstable polymerase-nucleoprotein interaction is not responsible for avian influenza virus polymerase restriction in human cells | Q39250932 | ||
| The host proteins transportin SR2/TNPO3 and cyclophilin A exert opposing effects on HIV-1 uncoating. | Q39253660 | ||
| Restriction of feline immunodeficiency virus by Ref1, Lv1, and primate TRIM5alpha proteins | Q39419407 | ||
| Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes | Q39870640 | ||
| Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome | Q40695371 | ||
| Transduction of nondividing human macrophages with gammaretrovirus-derived vectors | Q41889493 | ||
| Structural requirements for the antiviral activity of the human MxA protein against Thogoto and influenza A virus | Q41984285 | ||
| The interferon-inducible MxB protein inhibits HIV-1 infection. | Q42267969 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 9017-9026 | |
| P577 | publication date | 2014-06-04 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor | |
| P478 | volume | 88 |
| Q99550896 | A Potent Postentry Restriction to Primate Lentiviruses in a Yinpterochiropteran Bat |
| Q35641044 | A triple-arginine motif in the amino-terminal domain and oligomerization are required for HIV-1 inhibition by human MX2 |
| Q37034818 | Accumulation of MxB/Mx2-resistant HIV-1 Capsid Variants During Expansion of the HIV-1 Epidemic in Human Populations |
| Q39320682 | Capsid-Dependent Host Factors in HIV-1 Infection |
| Q35111033 | Contribution of MxB oligomerization to HIV-1 capsid binding and restriction |
| Q59355127 | Equine MX2 is a restriction factor of equine infectious anemia virus (EIAV) |
| Q58693128 | Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein |
| Q28551681 | Evolutionary Analyses Suggest a Function of MxB Immunity Proteins Beyond Lentivirus Restriction |
| Q37037995 | Expression levels of Fv1: effects on retroviral restriction specificities |
| Q57043865 | From APOBEC to ZAP: Diverse mechanisms used by cellular restriction factors to inhibit virus infections |
| Q38457723 | HIV suppression by host restriction factors and viral immune evasion |
| Q34473801 | HIV-1 and interferons: who's interfering with whom? |
| Q34422979 | Host and viral determinants for MxB restriction of HIV-1 infection |
| Q59351855 | Human MX2/MxB: a Potent Interferon-Induced Postentry Inhibitor of Herpesviruses and HIV-1 |
| Q59358015 | Human MxB Protein Is a Pan-herpesvirus Restriction Factor |
| Q58546274 | Human MxB inhibits the replication of HCV |
| Q38816438 | Interferon but not MxB inhibits foamy retroviruses |
| Q59356261 | MXB inhibits murine cytomegalovirus |
| Q26801484 | Misdelivery at the Nuclear Pore Complex-Stopping a Virus Dead in Its Tracks |
| Q64247477 | Multiple Roles of HIV-1 Capsid during the Virus Replication Cycle |
| Q59349565 | Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction |
| Q38834397 | Mx oligomer: a novel capsid pattern sensor? |
| Q38807646 | MxB Is Not Responsible for the Blocking of HIV-1 Infection Observed in Alpha Interferon-Treated Cells |
| Q92471253 | MxB Restricts HIV-1 by Targeting the Tri-hexamer Interface of the Viral Capsid |
| Q54207401 | MxB is an interferon-induced restriction factor of human herpesviruses. |
| Q96585128 | MxB sensitivity of HIV-1 is determined by a highly variable and dynamic capsid surface |
| Q47555067 | Naturally occurring mutations in HIV-1 CRF01_AE capsid affect viral sensitivity to restriction factors |
| Q56530177 | Nuclear pore heterogeneity influences HIV-1 infection and the antiviral activity of MX2 |
| Q36433874 | Oligomerization Requirements for MX2-Mediated Suppression of HIV-1 Infection |
| Q90689409 | Pro-515 of the dynamin-like GTPase MxB contributes to HIV-1 inhibition by regulating MxB oligomerization and binding to HIV-1 capsid |
| Q38899780 | Promotion of expression of interferon-stimulated genes in U937 monocytic cells by HIV RNAs, measured using stable isotope labeling with amino acids in cell culture (SILAC). |
| Q35914350 | Restriction of HIV-1 Requires the N-Terminal Region of MxB as a Capsid-Binding Motif but Not as a Nuclear Localization Signal |
| Q59358399 | Role of MxB in Alpha Interferon-Mediated Inhibition of HIV-1 Infection |
| Q37335524 | Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages |
| Q36121243 | Structural analysis of tumor-related single amino acid mutations in human MxA protein |
| Q34615762 | Structural insight into HIV-1 restriction by MxB. |
| Q56467498 | The 125th Lys and 145th Thr Amino Acids in the GTPase Domain of Goose Mx Confer Its Antiviral Activity against the Tembusu Virus |
| Q35639494 | The Broad-Spectrum Antiviral Protein ZAP Restricts Human Retrotransposition |
| Q64100581 | The ability of SAMHD1 to block HIV-1 but not SIV requires expression of MxB |
| Q41019959 | Transcription profiling of CD4⁺ T cells in rhesus macaques that infected with simian-human immunodeficiency virus and re-challenged with SIVmac251. |
Search more.